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rate of 45% in 190 patients undergoing EAAA repair
between 1992 and 1997. Later endograft designs seem to
have performed better,5 but recent reports of midterm
results still show a 25% to 35% clinical failure rate after
EAAA repair.3,6 Given these rather sobering data, are
there risk factors that might identify patients at higher risk
for EAAA repair failure who might be best served with
open repair?
Prudent patient selection, particularly in regard to
unfavorable anatomy, is emerging as perhaps the single
most important determinant of outcome after EAAA
repair. The purpose of this study was to examine one such
potential anatomic factor, that of significant aortic neck
angulation, on the incidence of acute and delayed adverse
events after EAAA repair.
METHODS
Patient selection. An endovascular AAA program was
started at the Ochsner Clinic in December 1995.
Prospectively collected data from 148 consecutive EAAA
repairs from December 1995 to January 2001 were
reviewed. This experience is inclusive of all EAAA repairs at
this institution and thus includes the early “learning curve”
with various endografts. These prospectively collected data
were supplemented with retrospective review of charts and
radiographs. Every effort was made to locate these preop-
Endovascular abdominal aortic aneurysm (EAAA)
repair has been embraced by patients and their physicians
because of its minimally invasive nature and the resulting
perception of lower morbidity rates. In some centers, as
many as 74% of infrarenal abdominal aortic aneurysm
(AAA) repairs are now being performed with endografts
instead of conventional open surgery.1 However, it has
become clear that EAAA repair can be associated with a
substantial risk of delayed complications that may com-
promise its ultimate durability.2,3
May et al4 were among the first to voice these con-
cerns when they described an overall adverse event rate
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Background: Significant aortic neck angulation may predispose to suboptimal outcome after endovascular abdominal
aortic aneurysm (EAAA) repair. However, the definition of “significant” neck angulation and its correlation with
adverse outcome are poorly characterized.
Methods: Prospectively collected data on 148 consecutive EAAA repairs performed between December 1995 and January
2001 were supplemented with retrospective review of charts and radiographs. Aortic neck angulation was measured
from arteriograms or three-dimensional computed tomography scanning reconstructions. Patients were excluded 
(n = 24) if radiographs were unavailable for review. Because of a paucity of severe aortic neck angulation in other endo-
graft groups, only patients treated with a modular bifurcated device (Medtronic) (n = 81) were included in the final
analysis. Mean time from implantation was 26.6 ± 9.2 months.
Results: The risk of a patient experiencing one or more adverse events was 70%, 54.5%, and 16.6% in those with severe
(≥60 degrees, n = 10), moderate (40 to 59 degrees, n = 11), and mild (<40 degrees, n = 60) aortic neck angulation,
respectively (P = .0003). Adverse events included death within 30 days (20% vs 0%, P = .0007), acute conversion to
open repair (20% vs 0%, P = .0007), aneurysm expansion (9.1% to 20% vs 1.7%, P = .034), device migration (20% to
30% vs 3.3%, P = .013), and type I endoleak (23.8% vs 8.3%, P = .033), all occurring with significantly greater inci-
dence in patients with moderate or severe aortic neck angulation when compared with those with mild angulation,
respectively. Aortic neck length and diameter, age, and medical comorbidities were not significantly different between
groups. 
Conclusion: Aortic neck angulation appears to be an important determinant of outcome after EAAA repair. Although
patients with mild angulation (<40 degrees) had favorable outcomes in this series, those with moderate (40 to 59
degrees) or severe angulation (≥60 degrees) had a 54% to 70% risk of one or more adverse events. Importantly, these
outcomes occurred in spite of an adequate length (>2 cm) of proximal aortic neck. On the basis of these data, great
caution should be exercised in recommending EAAA repair for patients with aortic neck angulation ≥40 degrees.
(J Vasc Surg 2002;35:482-6)
erative radiographs to measure aortic neck angulation,
including repeated requests for those studies that had been
performed outside of our institution. Because aortic neck
angulation was a primary focus of this study, patients in
whom this information was not available (n = 24) were
excluded from this analysis, leaving an initial study cohort
of 124. Of these patients, 9 were treated with EVT/Ancure
(Guidant, Indianapolis, Ind),7 34 with Zenith (Cook,
Bloomington, Ind),8 and 81 with AneuRx endografts
(Medtronic/AVE, Minneapolis, Minn).9,10 Because of the
small number of EVT/Ancure endografts used, these were
excluded from further analysis. No Zenith devices were
placed in patients with aortic neck angulation >60 degrees
because this was a specific exclusion for the phase II trial of
the Food and Drug Administration. Accordingly, this
patient cohort was also excluded, leaving a final study
cohort of 81 patients treated with the AneuRx endograft
(Table I). Most endografts were implanted as part of phase
II or III trials of the Food and Drug Administration.
Patients were enrolled in these trials with approval of
Ochsner’s institutional review board.
Endograft implantation. Endografts were implanted
by a multidisciplinary team of vascular surgeons (WCS,
SRM) and an interventional radiologist (YM). These pro-
cedures were performed in a standard operating room with
portable fluoroscopy equipment. Initial cases were per-
formed with general anesthesia, but spinal anesthesia was
used predominantly in the last 100 cases. Intravascular
ultrasound scanning was used routinely in the earlier part
of our experience but only sparingly in the last 50 to 60
cases. At the initial endovascular repair, every effort was
made to identify and treat type I and III endoleaks. Type
II and IV endoleaks were managed conservatively if they
were found during the initial EAAA repair. Additional
oblique completion arteriograms were obtained selectively
to minimize the risk of a type I or III endoleak being mis-
interpreted as a type II or IV endoleak. 
Clinical follow-up. Computed tomography scans
and plain abdominal radiograms were generally obtained
within 1 week of implantation and then at a minimum of
1 month, 6 months, 12 months, and yearly thereafter.
Evidence of a type I leak, a type II leak with an expanding
aneurysm, an expanding aneurysm without discernable
endoleak, significant device migration, component separa-
tion, or a pulsatile aneurysm on physical examinations all
generally prompted aortography and appropriate inter-
vention where indicated. 
Definitions. Aortic neck angulation was defined as
the angle between the proximal aortic neck and the longi-
tudinal axis of the aneurysm (Fig 1). A completely straight
neck would therefore have an angulation of zero, with
greater angulation correspondingly higher. These mea-
surements were taken from arteriograms, including lateral
views, or three-dimensional computed tomography recon-
structions. A protractor was used to measure the actual
angulation. The most severe angle was recorded for each
patient. One individual (GC) measured the angles, gener-
ally in “batches” of 5 to 10 sets of films as they became
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available. Therefore there was no intraobserver variability.
This information was subsequently added to the endovas-
cular database by the same individual at a later time, where
outcome data were also stored. Because the area for film
reading was geographically removed from the computer
storing the outcome data, these data were not immediately
available to the individual at the time of measuring the
angles. Thus, although the individual was not strictly
“blinded” to the outcome data, he did not generally know
this information before measuring the angles. 
Adverse outcomes examined included type I endoleak
(≥1 month after implantation), aneurysm expansion ≥5
mm, distal migration of the proximal end of the device ≥5
mm, need for a second procedure, acute or late conversion
to open repair, AAA rupture, or death within 30 days of
implantation. Some patients had more than one adverse
event. Intraoperative type I endoleaks or device migration
that were successfully treated at the initial implantation
were not considered an adverse outcome and are thus not
included in these data.
Statistics. Baseline characteristics were analyzed by use
of two-way analysis of variance. Adverse events were com-
pared by use of χ2 analysis. All data are mean ± standard
deviation. A significant P value was considered to be < .05.
Fig 1. Measurement of aortic neck angulation.
Table I. Endograft usage
Aortic angulation (degrees)
AneuRx Total <40 40-59 ≥60
Bifurcated 76 55 11 10
Tube* 5 5 0 0
Total 81 60 11 10
*These cases represent the use of “stacked” aortic cuffs to treat focal sac-
cular aneurysms.16
RESULTS
Eighty-one patients treated with the AneuRx endo-
graft had a mean time from implantation of 26.6 ± 9.2
months. The risk of one or more adverse events per
patient increased dramatically with increasing degree of
aortic neck angulation: 16.6% (10/60), 54% (6/11), and
70% (7/10) with mild (<40 degree), moderate (40 to 59
degrees), and severe (≥60 degrees) neck angulation,
respectively (P = .0003).
Early adverse events, including death (P = .0007) and
need for acute open conversion (P = .0007), were signifi-
cantly greater in patients with severe aortic neck angulation
(20% vs 0%) when compared with mild or moderate angu-
lation (Table II). Late adverse events, including aneurysm
expansion (P = .034), device migration (P = .013), and
type I endoleak (P = .033) were all significantly more com-
mon in patients with moderate or severe angulation when
compared with those patients with mild angulation. The
need for a secondary procedure increased fourfold (5% vs
18% to 20%) when comparing patients with mild versus
moderate or severe angulation, but these differences did
not achieve statistical significance (P = .142).
Baseline characteristics of the cohort groups are
detailed in Table III. There were no significant differences
in the three angulation cohorts in regard to age, medical
comorbidities, or American Society of Anesthesiologists
(ASA) classification. Anatomically, there was no difference
in aortic neck diameter (P = .88) or aortic neck length (P =
.33) between the groups. However, AAA size was signifi-
cantly larger (64.7 mm) in patients with severe angulation
when compared with those with moderate (53.2 mm) or
mild (59.1 mm) neck angulation (P = .01). The angle
between the suprarenal aorta and the infrarenal neck was
also greater in patients with severe aortic neck-aneurysm
angulation (32 ± 23.3 degrees) when compared with
patients with mild (3 ± 6.2 degrees) or moderate angulation
(8 ± 12.5 degrees). Operative time (“skin to skin”) was also
markedly longer in patients with severe neck angulation
(3.9 hours) versus patients with lesser angulation (2.3
hours, P = .005). Finally, length of stay was also significantly
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increased in those patients with severe neck angulation (5.7
days) when compared with patients with moderate (1.7
days) or mild (2.0 days) angulation (P = .016).
DISCUSSION
The presence of moderate (40% to 59%) or severe
(≥60 degree) aortic neck angulation was associated with a
significantly increased risk of adverse events after EAAA
repair. Importantly, these adverse events occurred in spite
of an adequate length (>2 cm) of proximal aortic neck.
This increased risk included both acute adverse events,
such as death and need for immediate open conversion, as
well the late adverse events of graft migration, aneurysm
expansion, and type I endoleak. There was a trend toward
more secondary procedures in patients with moderate
and severe angulation that did not reach statistical signif-
icance. Although the maximum incidence of any one
adverse event was 20%, 54% of patients with moderate
angulation (40 to 59 degree) and 70% of patients with
severe neck angulation (≥60 degree) had one or more
adverse events (Fig 2). In comparison, the cumulative risk
of an adverse event in those patients with mild neck angu-
lation (<40 degree) was relatively low (16.6%). The step-
wise increase in adverse events with degree of aortic neck
angulation, in spite of adequate aortic neck length, pro-
vides compelling evidence that this is an important vari-
able that affects outcome after EAAA repair when the
AneuRx device is used.
When late adverse adverse events were examined, it
appeared that moderate neck angulation was associated
with similar risks when compared with severe angulation.
Need for a secondary procedure (18% vs 20%), device
migration (30% vs 20%), and AAA expansion (9.1% vs
20%) were fairly similar between the groups with moder-
ate and severe neck angulation, respectively. Incidence of
type I endoleak was higher in patients with moderate
angulation (36.4%, 4/11) than severe angulation (10%,
1/10). This was an unexpected finding and may be
explained by the greater use of immediate adjunctive aor-
tic cuff use in patients with severe neck angulation, or sim-
ply a type I statistical error resulting from the small sample
size. The authors doubt that severe neck angulation has
less risk of type I endoleak than in patients with moderate
angulation. When the two groups were combined, the
endoleak rate for patients with neck angulation ≥40
degrees was 23.8% (5/21) versus 8.3% (5/60) in patients
with mild angulation (<40 degrees), nearly a threefold
increase. The most appropriate interpretation of these data
may be that, for AneuRx endografts, moderate neck angu-
lation confers the same risk of delayed type I endoleak as
does severe neck angulation.
The angle between the suprarenal aorta and infrarenal
aortic neck was significantly greater in patients who also
had severe angulation between the infrerenal aortic neck
and the aneurysm. The impact of this angulation is unclear
because the AneuRx endograft has no suprarenal fixation
and therefore does not cross this angle. The potential
influence of significant angulation of the suprarenal aorta
Fig 2. Cumulative risk of one or more adverse events occurring in
patients with mild, moderate, and severe aortic neck angulation.
may be more important with endografts such as Zenith
that have suprarenal fixation.
The positive correlation between aortic neck angula-
tion and adverse outcomes has been documented by oth-
ers. Albertini et al11 examined the influence of aortic neck
structure on the risk of either proximal type I endoleak or
graft migration. A “home-made” endograft was used (n =
184) consisting of Gianturco stents with barbs added, sewn
to a Dacron graft. Some patients had suprarenal fixation.
Unlike our study, Albertini et al11 included intraoperative
events as complications. Patients with type I endoleak or
graft migration had an average aortic neck angulation of 50
and 54 degrees, respectively, whereas those without these
complications had an average neck angulation of 37
degrees. Interestingly, other potential adverse neck
anatomy including an inverted funnel (flared) shape, pres-
ence of significant thrombus, atheroma, or calcification did
not have a positive correlation with these complications.
Although this study demonstrated that increasing neck
angulation was associated with these two particular adverse
events, the authors concluded that “this study provides no
data about cut-off values [for neck angulation] that could
be useful for patient selection.”11
Petrik and Moore12 studied the relationship of
endoleak with various anatomic characteristics of 100
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patients undergoing EAAA repair with the EVT/Ancure
device. As they excluded the 10% of patients requiring
acute open conversion, no comment could be made on
the effect of neck angulation on acute adverse events.
There was no significant difference in neck angulation
between those patients with type I endoleaks (n = 34, 21
degrees) versus those without type I endoleaks (n = 53, 22
degrees). However, no patient was treated with a greater
than 60 degree aortic neck, so no conclusions could be
drawn from this study regarding this device’s ability to
treat patients with severe angulation. 
Lamparello et al13 examined the association of
endoleak with anatomic characteristics in a cohort of 130
patients, more than 90% of which were treated with the
Ancure endograft. Patients were found to have a greater
risk of a type I endoleak if they had >60-degree aortic neck
angulation (28.6% vs 11%), an aortic neck < 15 mm
(26.1% vs 8.1%), or AAA size > 5.5 cm (22.4% vs 4.1%).
Large AAA ( > 5.5cm) had a greater propensity for shorter
necks (31.4% vs 11.4%) and severe (>60 degree) neck
angulation (15.9% vs 1.4%). Our study also demonstrated
a greater AAA size in patients with severe neck angulation.
Although speculative, this study and our own support the
hypothesis that adverse anatomy such as neck angulation
play a causative role in adverse events such as type I
Table III. Baseline characteristics
≤40 degrees (n = 60) 40 to 59 degrees (n = 11) ≥60 degrees (n = 10) P value
Aortic neck diameter (mm) 21.8 ± 2.6 23.3 ± 1.6 22.6 ± 2.4 .879
Aortic neck length (mm) 26.9 ± 11.6 22 ± 6.0 24.1 ± 13.4 .330
AAA diameter (mm) 53.2 ± 12.1 59.1 ± 8.7 64.7 ± 12.6 .011 
Suprainfra aortic angle 3 ± 6.2 8 ± 12.5 32 ± 23.3 .0005 
OR time (h) 2.3 ± 0.9 2.3 ± 0.7 3.9 ± 1.9 .005 
LOS (d) 2 ± 2.6 1.7 ± 0.5 5.7 ± 5.9 .016 
Age 73 ± 7.8 75 ± 5.8 77 ± 7.8 .396
ASA 3 ± 0.5 3 ± 0.7 3 ± 0.4 .663
CAD 33 (55%) 4 (36.4%) 3 (33.3%) .222
PAOD 21 (35%) 4 (36.4%) 4 (40%) .954
COPD 19 (31.7%) 6 (54.5%) 4 (40%) .332
CRI 2 (3.3%) 0 ( 0 ( .698
Hypertension 30 (50%) 4 (36.4%) 4 (40%) .633
CAD, Coronary artery disease; PVD, peripheral arterial occlusive disease; COPD, chronic obstructive pulmonary disease; CRI, chronic renal insufficiency.
Table II. Incidence of adverse events
≤40 degrees (n = 60) 40-59 degrees (n = 11) ≥60 degrees (n = 10) P value
Patients with one or more adverse events 10 (16.6%) 6 (54%) 7 (70%) .0003 
Death (≤30 days) 0 0 2 (20%) .0007 
Acute open conversion 0 0 2 (20%) .0007 
AAA expansion (≥5 mm) 1 (1.7%) 1 (9.1%) 2 (20%) .034 
Proximal migration (≥5 mm) 2 (3.3%) 3 (30%) 2 (20%) .013 
Need for second procedure 3 (5%) 2 (18%) 2 (20%) .142
Type I endoleak (≥1 month) 5 (8.3%) 4 (36.4%) 1 (10%) .033 
Late open conversion 0 1 (9.1%) 0 .04 
AAA rupture 0 0 0 1
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endoleak. AAA size likely acts as a marker for such adverse
anatomy rather than a primary causative factor.
Although this study can only comment on the corre-
lation of aortic neck angulation and adverse outcome with
the AneuRx device, the studies sited above suggest that
this finding is not device-specific. Similar findings for type
I endoleak were seen with an unsupported endograft with
hook fixation (Ancure), as well as a custom-made endo-
graft with both barb fixation and radial expansion (custom
Nottingham device). As such, severe aortic neck angula-
tion may adversely impact results of EAAA repair inde-
pendent of endograft type.
Aortic neck length and diameter were not significantly
different between the three angulation groups in this
study. These data suggest that significant aortic neck
angulation elevates the risk of adverse outcome indepen-
dent of aortic neck length or diameter. This conclusion is
at variance with the thought that a “long” aortic neck may
negate adverse effects of an angulated aortic neck. 
Patient age, medical comorbidities, and ASA class
were all similar in the patient cohorts. Thus these variables
did not appear to have an impact on the adverse outcomes
seen in this study. Both operative time and length of stay
(LOS) were significantly increased in patients with severe
neck angulation. An increase in operative time data likely
reflected the greater technical difficulty in treating patients
with severe angulation.14 The increased LOS reflected the
greater postoperative morbidity rate in this group and cer-
tainly widened the increased cost of endovascular treat-
ment when compared with open repair.15
In conclusion, aortic neck angulation appears to be an
important determinant of outcome after EAAA repair
when the AneuRx endograft is used. Most treated patients
had mild angulation, and this cohort had quite favorable
outcomes in this series. However, those with moderate or
severe angulation had a 54% to 70% chance of an adverse
outcome. On the basis of these data, great caution should
be exercised in recommending endovascular repair for
patients with aortic neck angulation ≥40 degrees.
We thank Richard Chambers, MSPH, for performing
the statistical analysis for this study.
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